Valuation: Coeptis Therapeutics

Market Cap 102M 88.57M 82.93M 75.86M 143M 9.72B 145M 970M 381M 4.86B 383M 375M 16.17B P/E 2024
-1.08x
P/E 2025 -5.06x
Enterprise Value 95.98M 83.29M 77.99M 71.34M 135M 9.14B 136M 912M 358M 4.57B 360M 353M 15.2B EV / Sales 2024
-
EV / Sales 2025 51.4x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-4.14%
Current month-75.98%
6 months-67.86%
Current year-72.35%
Current year 3.93
Extreme 3.93
17.27
1 year 3.93
Extreme 3.93
21.41
3 years 2.31
Extreme 2.31
27.6
5 years 2.31
Extreme 2.31
428.4
10 years 2.31
Extreme 2.31
428.4

Financials

2024 2025
Net sales - 1.36M 1.18M 1.11M 1.01M 1.91M 130M 1.94M 12.96M 5.09M 64.87M 5.12M 5.01M 216M
Net income -9.81M -8.52M -7.97M -7.29M -13.77M -935M -13.95M -93.29M -36.61M -467M -36.85M -36.05M -1.55B -11.92M -10.34M -9.68M -8.86M -16.72M -1.14B -16.94M -113M -44.46M -567M -44.74M -43.77M -1.89B
Net Debt 866K 752K 704K 644K 1.22M 82.51M 1.23M 8.23M 3.23M 41.22M 3.25M 3.18M 137M -6.08M -5.28M -4.94M -4.52M -8.53M -579M -8.65M -57.82M -22.69M -289M -22.84M -22.34M -963M
Logo Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Employees
5
Sector
-
Date Price Change Volume
26-08-06 US$3.940 -4.14% 286,111
26-08-05 US$4.110 -4.42% 764,464
26-08-04 US$4.300 -16.34% 755,255
26-08-03 US$5.140 +6.86% 309,390
26-07-31 US$4.810 -7.85% 299,459
  1. Stock Market
  2. Stocks
  3. COEP Stock